Inventor · disambiguated record
Philip M. Zakas
Also filed as: ZAKAS PHILIP · ZAKAS PHILIP M
5 granted patents·7 pending applications·8 citations·filing 2016–2025
70Inventor score
Top patents by PatentIndex Score
12 records- 0189US10654910B2Factor VIII proteins having ancestral sequences, expression vectors, and uses related theretoUNIV EMORY·Filed 2016·Granted May 19, 2020·7 cites·18 claims
- 0282US11046750B2Factor VIII proteins having ancestral sequences, expression vectors, and uses related theretoUNIV EMORY·Filed 2020·Granted Jun 29, 2021·1 cites·12 claims
- 0373US11897938B2Factor VIII proteins having ancestral sequences, expression vectors, and uses related theretoUNIV EMORY·Filed 2021·Granted Feb 13, 2024·0 cites·9 claims
- 0473US2025034232A1von Willebrand Factor Proteins for Treating Bleeding DisordersUNIV KINGSTON·Filed 2024·Application pending·0 cites
- 0563US2024294940A1Baculovirus expression systemBIOVERATIV THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0662US12364774B2Nucleic acid molecules and uses thereof for non-viral gene therapyBIOVERATIV THERAPEUTICS INC·Filed 2019·Granted Jul 22, 2025·0 cites·46 claims
- 0762US12116399B2Von Willebrand factor proteins for treating bleeding disordersUNIV KINGSTON·Filed 2018·Granted Oct 15, 2024·0 cites·14 claims
- 0859US2024350671A1Engineered itr sequences and methods of useBIOVERATIV THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0956US2023084036A1Optimized factor viii genesBIOVERATIV THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1055US2025269067A1Nucleic acid molecules and uses thereof for non-viral gene therapyBIOVERATIV THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1154US2022356490A1Baculovirus expression systemBIOVERATIV THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1247US2022243201A1Engineered itr sequences and methods of useBIOVERATIV THERAPEUTICS INC·Filed 2022·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →